Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Substance Olanzapine Trs

Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)

Open House Original Discount Contracts 2023-21 - Nepafenac

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredients Emtricitabine, Rilpivirine, Tenofovir Disoproxil

Drugs Containing the Active Substance Valproic Acid (Atc: N03ag01)

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Iron(Iii) Derisomaltose (B03ac08).

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Rituximab, Atc L01af01 for the Period August 1St, 2023 - July 31St, 2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V (Open House Model)

Uniha_Medication Supply

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Bimatoprost (S01ee03) as Part of a So-Called Open House Model.